Illumina, INC.
Sequencing and array-based solutions for genetic research, clinical and applied markets
Based in CA
🤖
AI Overview
With $1.6M in lobbying spend across 26 quarterly filings, Illumina, INC. is a significant lobbying presence.
$1.6M
Total Lobbying Spend
26
Quarterly Filings
1
Lobbying Firms Used
4
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2019 | $240K |
| 2020 | $180K |
| 2021 | $180K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $240K |
| 2025 | $240K |
Lobbying Firms
AVENUE SOLUTIONS
What They Lobby For
- Issues related to the genetic sequencing industry and the use of genetic information in research and clinical settings.
- Issues related to genetic sequencing industry and the use of genetic information in research and clinical settings; Discussions around reintroduction of H.R. 5062, Advancing Access to Precision Medicine Act from 115th Congress
- Policies impacting Medicare and Medicaid coverage and reimbursement for whole genome sequencing clinical laboratory services
- National Institutes of Health (NIH) funding
- Issues related to genetic sequencing industry and the use of genetic information in research and clinical settings;
- Policies impacting Medicaid coverage and reimbursement for whole genome sequencing clinical laboratory services; H.R. 4144, Ending the Diagnostic Odyssey Act of 2019
- National Institutes of Health (NIH) funding/All of Me program
- H.R. 4144/S. 3116, Ending the Diagnostic Odyssey Act of 2019
- Discussions related to genomics, sequencing and the applications for sequencing including in rare disease and related reimbursement. H.R. 4144/S. 3116, Ending the Diagnostic Odyssey Act of 2019; Public Law 116-136 - CARES Act; Public Law 116-139 - Paycheck Protection Program and Health Care Enhancement Act; H.R.6800, The Heroes Act; CDC surveillance funding
- Discussions related to genomics, sequencing and the applications for sequencing including in rare disease and related reimbursement; H.R. 4144/S. 3116, Ending the Diagnostic Odyssey Act of 2019; Public Law 116-136 - CARES Act; Public Law 116-139 - Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, The Heroes Act; H.R. 925, The Heroes Act; CDC surveillance funding; CURES 2.0 discussion draft
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.